Form D — Biolinq Inc
0001685406-25-000001 · filed Mar 21, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $100,000,000
- Reported amount sold
- $90,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Biolinq Inc
- CIK
- 1685406
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 10260 SORRENTO VALLEY ROAD
SAN DIEGO, California 92121 - Phone
- (510) 847-9655
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
RICHARD YANG · Executive OfficerSAN DIEGO, California Find on LinkedIn ↗
-
CHRIS DIMITROPOULOS · DirectorSAN DIEGO, California Find on LinkedIn ↗
-
DEREK RAPP · DirectorSAN DIEGO, California Find on LinkedIn ↗
-
THAD JOHNSON · DirectorSAN DIEGO, California Find on LinkedIn ↗
-
DAN BRADBURY · DirectorSAN DIEGO, California Find on LinkedIn ↗
-
ZINA AFFAS BESSE · DirectorSAN DIEGO, California Find on LinkedIn ↗
-
DAVID BERRY · DirectorSAN DIEGO, California Find on LinkedIn ↗
-
JARED AFFAS TANGNEY · Executive OfficerSAN DIEGO, California Find on LinkedIn ↗
-
DAVID ARIDA · Executive OfficerSAN DIEGO, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗